News
Medicare Is About to Cover Weight-Loss Drugs for the First Time — Here's What the GLP-1 Bridge Program Means for Millions of Americans with Obesity
Medicare's GLP-1 Bridge launches July 1, 2026, offering eligible Part D enrollees Wegovy and Zepbound for $50/month — the first-ever Medicare coverage for obesity-specific GLP-1 drugs.
→
Alzheimer's Treatment Is Entering a New Era — Here Is Everything That Has Changed in 2026
Leqembi and Kisunla are slowing Alzheimer's decline by 27-35% in early-stage patients. The 2026 drug pipeline has 158 candidates in 192 trials. Prevention trials are beginning. Here's the full update.
→
Mpox Clade I 2026: 23 U.S. Cases Confirmed, CDC Warns of More as World Cup Increases Travel Risk
CDC confirms 23 clade I mpox cases in the U.S. as of June 2026 — all travel-linked. Historically more severe than clade II. CDC expects additional cases as summer travel and World Cup activity peaks.
→
